Brachytherapy Market

Brachytherapy Market Size

Market Overview

Brachytherapy, also known as internal radiation therapy, is a type of radiotherapy in which radiation is delivered directly to a cancerous tumor in the body via a source placed close or next to it. The source emits gamma rays that target cancer cells while minimizing harm to healthy tissue nearby. Depending on the severity of the disease and its damage, brachytherapy is given at a Low Dose Rate (LDR) or a High Dose Rate (HDR). Small radioactive seeds are permanently implanted in or around the tumor in LDR, whereas radioactive sources are removed from the patient's body at the end of each session in HDR, which is utilized in high-risk tumors.

Brachytherapy Market: Key Players

• Argon Medical Devices

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

• Becton
• Dickinson and Company
• Carl Zeiss Meditec AG
• Eckert & Ziegler BEBIG S.A.
• Elekta AB, iCAD Inc.
• Isoray Inc.
• Theragenics Corporation
• iMedX Information Services
• Varian Medical Systems Inc.

Growth Factor

Rising prevalence of different types of cancer

Brachytherapy has been shown to be an exceptionally successful treatment choice for cervical, skin, and breast cancers, which is fueling market expansion. Furthermore, the availability of high-quality brachytherapy equipment that delivers precise and very localized radiation doses to tiny tumors has increased patient and medical professional acceptance of the therapy.

Growing medical tourism 

Growing medical tourism across the world, as well as increased knowledge of the benefits of brachytherapy, its cost-effectiveness, and higher cure rate when compared to surgery or external beam treatment (EBT), is propelling the industry forward.

Segmentation

• By Technique
  • High Dose Rate Brachytherapy Devices
  • Low Dose Rate Brachytherapy Devices
• By Application
  • Gynecologic Cancer
  • Prostate Cancer
  • Breast Cancer
  • Others
• By End User:
  • Hospitals
  • Clinics
  • Clinical Laboratories
  • Academic Medical Centers
  • Others
• Brachytherapy Market Dynamics
• Brachytherapy Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

Recent News Related to Market

1. In 2020, the HDR brachytherapy category led the market, accounting for 71.2 percent of total revenue.

2. This category is predicted to develop due to the launch of innovative products such as GammaTile for the treatment of brain cancer. IsoRay gained FDA 510K approval for this device in July 2018, which employs Cesium-131 seeds, which have a lower risk of side effects than other regularly used LDR isotopes.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

• COVID-19 pre and post business impact analysis
• Detailed overview of the parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• What is the Brachytherapy Market growth?
• Which segment accounted for the largest Brachytherapy Market share?
• Who are the key players in the Brachytherapy Market?
• Historical, current, and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Frequently Asked Questions (FAQ):